Evaluation of the frequency of mutation genes in multidrug-resistant tuberculosis (MDR-TB) strains in Beijing, China

被引:10
|
作者
Liu, Y. [1 ]
Sun, Y. [1 ]
Zhang, X. [1 ]
Zhang, Z. [2 ]
Xing, Q. [3 ]
Ren, W. [1 ]
Yao, C. [1 ]
Yu, J. [1 ]
Ding, B. [3 ]
Wang, S. [3 ]
Li, C. [1 ]
机构
[1] Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Dept Bacteriol & Immunol,Beijing Key Lab Drug Res, Beijing 101149, Peoples R China
[2] Beijing Changping Ctr TB Control & Prevent, Beijing 102200, Peoples R China
[3] Beijing Res Inst TB Control, Cent Lab, Beijing 100035, Peoples R China
关键词
Beijing genotype; isoniazid; multidrug-resistant tuberculosis (MDR-TB); Mycobacterium tuberculosis; rifampin; MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR CHARACTERISTICS; DRUG-RESISTANCE; ISONIAZID RESISTANCE; KATG; PREVALENCE; MECHANISMS;
D O I
10.1017/S0950268820003131
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The aim of this study was to explore the frequency and distribution of gene mutations that are related to isoniazid (INH) and rifampin (RIF)-resistance in the strains of the multidrug-resistant tuberculosis (MDR-TB) Mycobacterium tuberculosis (M.tb) in Beijing, China. In this retrospective study, the genotypes of 173 MDR-TB strains were analysed by spoligotyping. The katG, inhA genes and the promoter region of inhA, in which genetic mutations confer INH resistance; and the rpoB gene, in which genetic mutations confer RIF resistance, were sequenced. The percentage of resistance-associated nucleotide alterations among the strains of different genotypes was also analysed. In total, 90.8% (157/173) of the MDR strains belonged to the Beijing genotype. Population characteristics were not significantly different among the strains of different genotypes. In total, 50.3% (87/173) strains had mutations at codon S315T of katG; 16.8% (29/173) of strains had mutations in the inhA promoter region; of them, 5.5% (15/173) had point mutations at -15 base (C -> T) of the inhA promoter region. In total, 86.7% (150/173) strains had mutations at rpoB gene; of them, 40% (69/173) strains had mutations at codon S531L of rpoB. The frequency of mutations was not significantly higher in Beijing genotypic MDR strains than in non-Beijing genotypes. Beijing genotypic MDR-TB strains were spreading in Beijing and present a major challenge to TB control in this region. A high prevalence of katG Ser315Thr, inhA promoter region (-15C -> T) and rpoB (S531L) mutations was observed. Molecular diagnostics based on gene mutations was a useful method for rapid detection of MDR-TB in Beijing, China.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines
    Prabowo, Satria A.
    Groeschel, Matthias I.
    Schmidt, Ed D. L.
    Skrahina, Alena
    Mihaescu, Traian
    Hasturk, Serap
    Mitrofanov, Rotislav
    Pimkina, Edita
    Visontai, Ildik
    de Jong, Bouke
    Stanford, John L.
    Cardona, Pere-Joan
    Kaufmann, Stefan H. E.
    Werf, Tjip S. van der
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2013, 202 (02) : 95 - 104
  • [2] Management and control of multidrug-resistant tuberculosis (MDR-TB): Addressing policy needs for India
    Atre, Sachin R.
    Murray, Megan B.
    JOURNAL OF PUBLIC HEALTH POLICY, 2016, 37 (03) : 277 - 299
  • [3] Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
    Ali, Monadil H.
    Alrasheedy, Alian A.
    Hassali, Mohamed Azmi
    Kibuule, Dan
    Godman, Brian
    ANTIBIOTICS-BASEL, 2019, 8 (03):
  • [4] Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB
    Al-Mutairi, Noura M.
    Ahmad, Suhail
    Mokaddas, Eiman M.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2019, 24 (01)
  • [5] Clinical risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Mali
    Baya, Bocar
    Achenbach, Chad J.
    Kone, Bourahima
    Toloba, Yacouba
    Dabitao, Djeneba K.
    Diarra, Bassirou
    Goita, Drissa
    Diabate, Seydou
    Maiga, Mamoudou
    Soumare, Dianguina
    Ouattara, Khadidia
    Kanoute, Tenin
    Berthe, Gaoussou
    Kamia, Youssouf M.
    Sarro, Yeya Dit Sadio
    Sanogo, Moumine
    Togo, Antieme C. G.
    Dembele, Bindongo P. P.
    Coulibaly, Nadie
    Kone, Amadou
    Akanbi, Maxwell
    Belson, Michael
    Dao, Sounkalo
    Orsega, Susan
    Siddiqui, Sophia
    Doumbia, Seydou
    Murphy, Robert L.
    Diallo, Souleymane
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 81 : 149 - 155
  • [6] Study of the prevalence of Multidrug-Resistant Pulmonary Tuberculosis (MDR-TB) in Western Rajasthan using line probe assay
    Sharma, Mukesh
    Kumar, Deepak
    Bohra, Gopal K.
    Meena, Durga S.
    Bhambu, Sunil K.
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2020, 9 (02) : 1093 - 1097
  • [7] Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB)
    Liu, Yongge
    Matsumoto, Makoto
    Ishida, Hidekaza
    Ohguro, Kinue
    Yoshitake, Masuhiro
    Gupta, Rajesh
    Geiter, Lawrence
    Hafkin, Jeffrey
    TUBERCULOSIS, 2018, 111 : 20 - 30
  • [8] GeneXpert MTB/RIF Is Superior to BBD Max MDR-TB for Diagnosis of Tuberculosis (TB) in a Country with Low Incidence of Multidrug-Resistant TB (MDR-TB)
    Mokaddas, E. M.
    Ahmad, S.
    Eldeen, H. S.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2019, 57 (06)
  • [9] Prevalence and Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) among Presumptive MDR-TB Patients in Tigray Region, Northern Ethiopia
    Mehari, Kibriti
    Asmelash, Tsehaye
    Hailekiros, Haftamu
    Wubayehu, Tewolde
    Godefay, Hagos
    Araya, Tadele
    Saravanan, Muthupandian
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2019, 2019
  • [10] Multidrug-resistant tuberculosis (MDR-TB) disease burden in China: a systematic review and spatio-temporal analysis
    Ding, Peipei
    Li, Xiaowen
    Jia, Zhongwei
    Lu, Zuhong
    BMC INFECTIOUS DISEASES, 2017, 17